The purpose of this contract is to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid…
Ended Definitive Contract Awarded
- Contract number
- 75F40125C00063
- Awardee
-
Universitat ST. Gallen UEI LLK6D5M1UAF1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $515,770
Award facts
- Opportunity
-
- FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2500123 · Posted Oct 3, 2024
- Contract value 100% obligated
- $515,769.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Food and Drug Administration (FDA) awarded a $515,769.89 firm fixed price definitive contract to the University of St. Gallen, a Swiss educational institution, to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid artificial intelligence to improve risk identification. This contract was awarded under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science, which solicits proposals to advance scientific knowledge in areas that support the FDA's mission of protecting and promoting public health. The contract does not have a set-aside designation.
Description
The purpose of this contract is to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid artificial intelligence to improve risk identification USI
Quick answers
Who was awarded contract 75F40125C00063?
75F40125C00063 was awarded to Universitat ST. Gallen by Food and Drug Administration (Department of Health and Human Services) on September 8, 2025.
How much is contract 75F40125C00063 worth?
The government has obligated $515,770 on 75F40125C00063.
Was contract 75F40125C00063 competed?
The extent of competition for 75F40125C00063 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award